78 related articles for article (PubMed ID: 10582204)
1. Desensitization to azathioprine.
Domínguez Ortega J; Robledo T; Martínez-Cócera C; Alonso A; Cimarra M; Chamorro M; Plaza A
J Investig Allergol Clin Immunol; 1999; 9(5):337-8. PubMed ID: 10582204
[TBL] [Abstract][Full Text] [Related]
2. A randomized pilot trial comparing cyclosporine and azathioprine for maintenance therapy in diffuse lupus nephritis over four years.
Moroni G; Doria A; Mosca M; Alberighi OD; Ferraccioli G; Todesco S; Manno C; Altieri P; Ferrara R; Greco S; Ponticelli C
Clin J Am Soc Nephrol; 2006 Sep; 1(5):925-32. PubMed ID: 17699309
[TBL] [Abstract][Full Text] [Related]
3. Adverse events and efficacy of TNF-alpha blockade with infliximab in patients with systemic lupus erythematosus: long-term follow-up of 13 patients.
Aringer M; Houssiau F; Gordon C; Graninger WB; Voll RE; Rath E; Steiner G; Smolen JS
Rheumatology (Oxford); 2009 Nov; 48(11):1451-4. PubMed ID: 19748965
[TBL] [Abstract][Full Text] [Related]
4. Reversible posterior leukoencephalopathy caused by azathioprine in systemic lupus erythematosus.
Foocharoen C; Tiamkao S; Srinakarin J; Chamadol N; Sawanyawisuth K
J Med Assoc Thai; 2006 Jul; 89(7):1029-32. PubMed ID: 16881437
[TBL] [Abstract][Full Text] [Related]
5. Acute pancreatitis associated with long-term azathioprine therapy. Occurrence in a patient with systemic lupus erythematosus.
Herskowitz LJ; Olansky S; Lang PG
Arch Dermatol; 1979 Feb; 115(2):179. PubMed ID: 426524
[TBL] [Abstract][Full Text] [Related]
6. A case of systemic lupus erythematosus presenting with protein-losing enteropathy.
Türkçapar N; Ozyüncü N; Cinar K; Ensari A; Küçük O; Idilman R; Duman N; Ozden A
Turk J Gastroenterol; 2006 Sep; 17(3):226-30. PubMed ID: 16941261
[TBL] [Abstract][Full Text] [Related]
7. Histologic deterioration and more flares: the case against azathioprine plus methylprednisolone in the treatment of proliferative lupus nephritis.
Chan TM
Arthritis Rheum; 2007 Mar; 56(3):702-4. PubMed ID: 17328038
[No Abstract] [Full Text] [Related]
8. Acute nonlymphocytic leukemia after treatment of systemic lupus erythematosus with immunosuppressive agents.
Vasquez S; Kavanaugh AF; Schneider NR; Wacholtz MC; Lipsky PE
J Rheumatol; 1992 Oct; 19(10):1625-7. PubMed ID: 1464880
[TBL] [Abstract][Full Text] [Related]
9. Protein-losing enteropathy as initial manifestation of systemic lupus erythematosus.
Carneiro FO; Sampaio LR; Brandão LA; Braga LL; Rocha FA
Lupus; 2012 Apr; 21(4):445-8. PubMed ID: 21997967
[TBL] [Abstract][Full Text] [Related]
10. Frequency of adverse drug reactions in patients with systemic lupus erythematosus.
Pope J; Jerome D; Fenlon D; Krizova A; Ouimet J
J Rheumatol; 2003 Mar; 30(3):480-4. PubMed ID: 12610805
[TBL] [Abstract][Full Text] [Related]
11. The relationship between cancer and medication exposures in systemic lupus erythaematosus: a case-cohort study.
Bernatsky S; Joseph L; Boivin JF; Gordon C; Urowitz M; Gladman D; Fortin PR; Ginzler E; Bae SC; Barr S; Edworthy S; Isenberg D; Rahman A; Petri M; Alarcón GS; Aranow C; Dooley MA; Rajan R; Sénécal JL; Zummer M; Manzi S; Ramsey-Goldman R; Clarke AE
Ann Rheum Dis; 2008 Jan; 67(1):74-9. PubMed ID: 17545189
[TBL] [Abstract][Full Text] [Related]
12. Azathioprine induced pancytopenia: a serious complication.
Hadda V; Pandey BD; Gupta R; Goel A
J Postgrad Med; 2009; 55(2):139-40. PubMed ID: 19550063
[TBL] [Abstract][Full Text] [Related]
13. Azathioprine-induced hypersensitivity reaction mimicking sepsis in a patient with systemic lupus erythematosus.
McKenzie PL; Chao Y; Pathak S; Kazi S
Mod Rheumatol Case Rep; 2023 Jan; 7(1):74-77. PubMed ID: 35975549
[TBL] [Abstract][Full Text] [Related]
14. Azathioprine hypersensitivity in a patient affected by systemic lupus erythematosus.
Caramaschi P; Biasi D; Carletto A; Bambara LM
Lupus; 1997; 6(7):616-7. PubMed ID: 9302667
[No Abstract] [Full Text] [Related]
15. A 'de novo' arisen case of angioedema C1-inhibitor deficiency dependent: possible mutagenic effect of azathioprine?
Guastafierro S; D'Apuzzo A; Verrazzo G; Lucivero G; Coppola L
Biomed Pharmacother; 1999 Jun; 53(5-6):284-5. PubMed ID: 10424251
[TBL] [Abstract][Full Text] [Related]
16. Acute leukemia after azathioprine treatment of connective tissue disease.
Alexson E; Brandt KD
Am J Med Sci; 1977; 273(3):335-40. PubMed ID: 266841
[TBL] [Abstract][Full Text] [Related]
17. Reactivation of Chagas disease by immunosuppressive therapy in a patient with systemic lupus erythematosus: report of an exceptional case.
Burgos LG; Ortiz BD; Canese A; Ojeda A; Melo M
Am J Dermatopathol; 2012 Aug; 34(6):e84-9. PubMed ID: 22814327
[TBL] [Abstract][Full Text] [Related]
18. Safety and efficacy of tumor necrosis factor alpha blockade in systemic lupus erythematosus: an open-label study.
Aringer M; Graninger WB; Steiner G; Smolen JS
Arthritis Rheum; 2004 Oct; 50(10):3161-9. PubMed ID: 15476222
[TBL] [Abstract][Full Text] [Related]
19. Azathioprine-induced fatal myelosuppression in systemic lupus erythematosus patient carrying TPMT*3C polymorphism.
Boonsrirat U; Angsuthum S; Vannaprasaht S; Kongpunvijit J; Hirankarn N; Tassaneeyakul W; Avihingsanon Y
Lupus; 2008 Feb; 17(2):132-4. PubMed ID: 18250137
[TBL] [Abstract][Full Text] [Related]
20. Update on the treatment of lupus nephritis.
Hogan J; Appel GB
Curr Opin Nephrol Hypertens; 2013 Mar; 22(2):224-30. PubMed ID: 23328501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
